Ad
related to: statistically significant
Search results
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 55 minutes agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Ángel Hernández, controversial umpire scorned by players and fans, retires after 33-year career
CBS News· 4 hours agoLongtime umpire Ángel Hernández, who unsuccessfully sued Major League Baseball for racial...
Insmed shares skyrocket on positive trial results for lung drug By Proactive Investors
Investing.com· 2 hours agoThe company said patients in the study with non-cystic fibrosis bronchiectasis who were dosed with...
Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
Zacks via Yahoo Finance· 5 hours agoAcrivon Therapeutics achieved statistically significant prospective validation of its AP3 patient...
Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?
Benzinga via Yahoo Finance· 4 hours agoInsmed Incorporated (NASDAQ:INSM) shares are trading higher after the company released topline...
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
FOX 23 News Albany· 1 day agoHighlights: Statistically significant improvement from baseline assessed by both clinicians and...
Much-maligned umpire Ángel Hernández to retire from Major League Baseball
Gannett via AOL· 3 hours agoDistrict Court in 2021, granting MLB a summary judgement. The 2nd Circuit U.S. Court of Appeals...
Insmed’s shares double as lung disease med powers past expectations in phase 3
FierceBiotech· 4 hours agoInsmed’s medicine didn’t just reduce exacerbations of a chronic lung disease in a phase 3 trial. The...
Neuren Pharmaceuticals’ NNZ-2591 shows promise in trial for Pitt Hopkins syndrome
Clinical Trials Arena via Yahoo Finance· 8 hours agoSafety, tolerability and pharmacokinetics were the trial's primary endpoints, while its secondary...
Why Is Insmed (INSM) Stock Up 134% Today?
InvestorPlace· 6 hours agoInsmed (NASDAQ:INSM) stock is rising higher on Tuesday after the company announced positive results from a Phase 3 clinical trial of brensocatib in...
